• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Severe Pneumonia Caused by Influenza A (H1N1) Virus Successfully Managed with Extracorporeal Life Support in a Comorbid Former Preterm Infant

tetano

Editor, Senior Moderator
Int J Environ Res Public Health. 2017 Mar 31;14(4). pii: E360. doi: 10.3390/ijerph14040360.
[h=1]Severe Pneumonia Caused by Influenza A (H1N1) Virus Successfully Managed with Extracorporeal Life Support in a Comorbid Former Preterm Infant.[/h] Raffaeli G[SUP]1[/SUP], Cavallaro G[SUP]2[/SUP], Pugni L[SUP]3[/SUP], Leva E[SUP]4[/SUP], Artoni A[SUP]5[/SUP], Neri S[SUP]6[/SUP], Baracetti C[SUP]7[/SUP], Cotza M[SUP]8[/SUP], Gentilino V[SUP]9[/SUP], Terranova L[SUP]10[/SUP], Esposito S[SUP]11,[/SUP][SUP]12[/SUP], Mosca F[SUP]13[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A (H1N1) virus infection is a global health burden, leading to significant pediatric morbidity and mortality. Prematurity, young age and comorbidities are important risk factors for unfavorable outcomes. Preventive strategies, such as healthcare workers and household contacts vaccination as well as the implementation of infection control practices during the epidemic season, are crucial to protect the most vulnerable populations. Early diagnosis, timely administration of antiviral drugs and supportive therapy are crucial to lead to a complete recovery. When conventional treatment fails, extracorporeal life support (ECLS) may be employed. In neonates and young infants, this high-tech support is burdened by specific technical complexity. Despite the potential risks related to this aggressive approach, ECLS is a life-saving procedure in 65% of pediatric viral pneumonia and in 73% of sepsis cases. Here, we report the successful outcome of a 51-day formerly preterm infant, suffering from a surgical necrotizing enterocolitis (NEC), complicated with hospital-acquired pneumonia due to influenza A (H1N1) virus. She developed a severe respiratory failure, unresponsive to conventional therapy, and successfully treated with ECLS. To our knowledge, this is the first report on the use of ECLS in a formerly preterm infant, suffering from NEC complicated by influenza A (H1N1) virus infection.


[h=4]KEYWORDS:[/h] extracorporeal life support (ECLS); infection control measures; influenza A (H1N1) virus; neonatal intensive care unit; neonate; oseltamivir; pneumonia; preterm infant; young infant

PMID: 28362356 DOI: 10.3390/ijerph14040360
 
Back
Top Bottom